E

PAVmed Inc. PAVM

$3.85 -$0.04-0.90% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

PAVmed Inc. is a diversified commercial-stage medical technology company focused on developing, acquiring, and commercializing healthcare products and technologies across multiple clinical areas. The company operates primarily in the medical device and digital health industries, with activities spanning minimally invasive technologies, diagnostics, cancer detection, and healthcare infrastructure solutions. PAVmed’s business model combines internal product development with majority-controlled subsidiaries that pursue targeted commercialization strategies in specialized healthcare markets.

The company’s primary revenue drivers and strategic focus have centered on its ownership interests in Lucid Diagnostics Inc., which develops esophageal precancer detection technologies, and Veris Health Inc., a digital health and remote patient monitoring platform. Historically, PAVmed also developed products in areas such as infusion therapy and gastrointestinal technologies. Founded in 2014 by medical device entrepreneur Lishan Aklog, the company evolved from a single-product development platform into a holding-company-style healthcare technology organization with multiple operating subsidiaries and public market financing relationships.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
52-Week Range1% of range
Low
$3.70
Current
$3.85
High
$28.44
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
917 813 1828
Address
360 Madison Avenue
25th Floor
New York, NY 10017
Country
Year Founded

Headlines

8/15/2026 - Nasdaq News: Markets
8/14/2026 - Seeking Alpha: Transcripts
7/16/2026 - TipRanks: TheFly